Domestic MedTech Industry Challenges Gujarat’s Stent Pricing Policy Favoring USFDA-Approved Devices

A controversial new stent pricing policy in Gujarat has ignited a firestorm, pitting domestic manufacturers against global giants in a high-stakes fight over India’s coronary stent market The Gujarat government’s recent decision to implement a dual pricing structure for drug-eluting stents (DES) has ignited controversy within India’s medical device sector. Under this new policy\